PUBLISHED DATE : Aug 2023 | Pages : 273
Fill out your details & get your free sample
Europe E-Pharmacy Market Size, Share, and Trends Analysis
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2023–2028
273 Pages
98 Tables
114 Charts
3 Regions
15 Countries
49 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 65.47 Billion |
| Market Size (2022) | USD 24.69 Billion |
| CAGR (2022-2028) | 17.65% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Medicine Type, Platform, Age Group, Product, and Geography |
| Geographic Analysis | EU-4 & UK, Central and Eastern Europe, and Nordic Countries |
| KEY VENDORS | DocMorris AG (Zur Rose Group) and Shop Apotheke |
The Europe e-pharmacy market was valued at USD 24.69 billion in 2022 and is expected to reach USD 65.47 billion by 2028, growing at a CAGR of 17.65%. Europe is going through a major shift with a growing number of people suffering from chronic diseases. Patients are usually required to take their medicines over the long term. However, they end up not taking their medicines as prescribed due to the inconvenience of purchasing them or not finding pharmacy stores if they live in rural areas. Further, with busy lifestyles, healthcare often takes a backseat for most people. As a result of this struggle, people have started to turn to the Internet to order medicines, propelling the Europe e-pharmacy market growth.
E-pharmacies: the existence of an online pharmacy that offers medical care and solutions providers the ability to prescribe medicines for consumers online. In Europe, the European Association of E-pharmacies (EAEP) stated that the members of EAEP are continuously increasing and improving the quality, safety, and efficiency of healthcare delivery for Europe people. E-pharmacies are currently supplying millions of people across the region with medicine. Also, online medicine shoppers appreciate the transparency, cost benefits, east processes, and delivery to their homes and take advantage of discreet & high-quality pharmaceutical consulting services. The Europe e-pharmacy market is trending in most of the region’s developing and developed countries. The trend from offline to online is the future, and there is a major growth potential for online pharmacies in Southern European countries such as France, Germany, Italy, and Spain. The fastest-growing regional market in Germany due to the increasing internet penetration and rising awareness regarding online over-the-counter benefits.
Rapidly Growing E-Health & E-prescription
Due to the progressive nature of healthcare and medicine deliveries in Europe, the approach changing from hospital care to homecare deliveries offers huge opportunities in European patient management across all healthcare systems. Growing adoption of e-health solutions such as m-health, telemedicine, and e-prescription help consumers connect directly to health professionals and receive care and consultations at home. Increasing use of e-health applications and increasing allowance to e-prescription drive the high medicine purchasing orders through e-pharmacies that have recently accelerated the Europe e-pharmacy market growth.
Integration of AI, & IoT
Technologies such as artificial intelligence (AI), Machine Learning, and the Internet of Things can potentially make pharmacy technologies more powerful. Europe is a technology-driven market for healthcare systems and pharmaceutical industries. Pharmacies with AI, Machine Learning offer multiple benefits, such as data processing, enabling pharmacists to make quick data-backed decisions and improve customer services. Furthermore, with IoT, drug inventory management will be faster and more accurate; through device-to-device communication. To accelerate performance advancement, pharmacists must be skilled at using emerging technologies of all kinds.
Strategic Operations for Market Expansion by Vendors
The European e-pharmacy market is witnessing massive development with several business strategies implementation. Several strategic partnerships, collaborations, and mergers & acquisitions have been registered in the Europe e-pharmacy market in recent years. Some leading industry players are considering strategic and opportunistic acquisitions of other companies, businesses, or assets. In 2023, the leading industry player SHOP APOTHEKE EUROPE and Galenica entered into a strategic partnership and established MediService Ltd leading online pharmacy in Switzerland.
INSIGHTS BY MEDICINE TYPE
The Europe e-pharmacy market by medicine type is segmented into over-the-counter (OTC) and prescription. OTC medicine types, including health & wellness and nutrition, dietary supplements, personal care, and cosmetic care solutions, are commonly and majorly ordered by people. The OTC segment accounted for the largest segmental revenue share in 2022. In Europe, most countries experienced a high demand for OTC products. In 2018, Roblek et al. found that customer expresses three typical online behaviors of OTC drugs: searching for information about OTC medicines without any particular purpose, buying OTC medicines, and searching for particular products or information.
INSIGHTS BY PLATFORM
The mobile platform segment accounted for the largest revenue share in the Europe e-pharmacy market in 2022. The increasing prevalence of chronic diseases drives awareness about medications and therapies in developed countries such as Germany, France, Switzerland, Italy, the UK, Spain, and others witnessed increasing use of mobile devices and associated applications to buy medicines online. Online pharmacies are witnessing the high growth and demand for medicines through smartphones and tablets.
INSIGHTS BY AGE GROUP
The below-50 age group segment dominated the Europe e-pharmacy market share in 2022. The below-50 age group highly uses internet services & smartphones and highly prefers buying medicine from online pharmacies. The penetration of e-commerce shopping preference accelerates the higher segmental growth.
INSIGHTS BY PRODUCT
The Europe e-pharmacy market by product types includes medications, health & wellness and nutrition, personal care & essentials, and others. The medications segment accounted for the industry's highest revenue share of over 75% in 2022. Online pharmacies purchase mostly prescription drugs associated with viral infections such as cold and flu, cough, diabetes-associated drugs, cancer care drugs, etc. On another side, opioids, slimming tablets, and hypnotic and sedative agents are some of the prescription medicines highly sold in Europe.
EU-4 & UK is a major region in the Europe e-pharmacy market with high development in the pharmaceutical industry, research and development, production, sale, marketing, and distribution. The huge patient population and higher health expenditures by patients are accelerating the application of rate of e-pharmacy websites and mobile applications. In 2022, EU-4 & UK region accounted for the highest share of over 59% in the Europe e-pharmacy market. In EU-4 & UK region, major countries such as Germany and the UK have made major progress in the e-pharmacy network. The presence of major and emerging e-pharmacies accelerates regional growth. On another side, the growing patient population and rising expenditure on health propelling regional growth. Furthermore, Italy and Spain have shown rapid growth in e-pharmacies. Leading industry players such as shop-apotheke.com (SHOP APOTHEKE) state that Italy is a rapidly growing market for e-pharmacies due to increasing e-commerce and internet penetration simultaneously increasing in the country.
In the Europe e-pharmacy market, several local/traditional/offline and online pharmacies are present in the region, significantly driving the competitive rivalry. In addition, the access to e-commerce channels and their involvement in medication deliveries make the European e-pharmacy market highly competitive. The e-commerce channels allow European pharmacies to provide/offer a wider range of products than local pharmacies, not constrained by the amount of physical shelf storage space.
The industry is growing healthy as the online pharma distribution channel has become the most common way of buying OTC and prescription medical products, especially during the Covid-19 pandemic. There is a high penetration of the Europe e-pharmacy market in the Netherlands, the UK, Switzerland, and Germany in the European Union. Further, DocMorris (Zur Rose Group) and SHOP APOTHEKE from the Netherlands are key players in the Europe e-pharmacy market. They have fought court battles for market access and freedom to set their respective prices in the country. These two players have already acquired other major and minor players to increase their market share and use their resources to the optimum limit. They are using the acquisition strategy to expand in the industry.
Frequently Asked Questions
How big is the Europe e-pharmacy market?
The Europe e-pharmacy market size was valued at USD 24.69 billion in 2022 and is expected to reach USD 65.47 billion by 2028.
What is the growth rate of the Europe e-pharmacy market?
The Europe e-pharmacy market is growing at a CAGR of 17.65% from 2022-2028.
What are the growing trends in the Europe e-pharmacy market?
The growing trends in the Europe e-pharmacy market are rapidly growing e-health & e-prescription, integration of AI, & IoT, strategic operations for market expansion by vendors, and integrating e-pharmacies with a delivery management solution
Which region holds the most significant Europe e-pharmacy market share?
The EU-4 & UK dominated the Europe e-pharmacy market share, capturing a significant share of approximately 59% in 2022.
Who are the key players in the Europe e-pharmacy market?
DocMorris AG (Zur Rose Group) and Shop Apotheke are the key players in the Europe e-pharmacy market.
The Europe e-pharmacy market is expected to grow at a CAGR of approximately 17.65% from 2022 to 2028.
The following factors are likely to contribute to the growth of the Europe e-pharmacy market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the Europe e-pharmacy market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Other Prominent Vendors
Segmentation by Medicine Type
Segmentation by Platform
Segmentation by Age Group
Segmentation by Product
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY MEDICINE TYPE
4.3.2 MARKET SEGMENTATION BY PLATFORM
4.3.3 MARKET SEGMENTATION BY PRODUCT TYPE
4.3.4 MARKET SEGMENTATION BY AGE GROUP
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
8.1.1 EUROPE E-PHARMACY MARKET OUTLOOK
8.1.2 GLOBAL E-PHARMACY MARKET OUTLOOK
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASED E-HEALTH & E-PRESCRIPTION SERVICES
9.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS
9.3 STRATEGIC ACQUISITIONS FOR MARKET EXPANSION
9.4 INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS
10 MARKET GROWTH ENABLERS
10.1 INTERNET PENETRATION AMONG PATIENT POPULATION
10.2 INCREASED HOME HEALTHCARE DELIVERIES
10.3 INCREASED HEALTH AWARENESS & SELF-MEDICATION
10.4 INCREASED PATIENT POPULATION
11 MARKET RESTRAINTS
11.1 STRINGENT REGULATORY NORMS
11.2 DATA BREACH & PRIVACY ISSUES
11.3 COMPETITION FROM TRADITIONAL PHARMACIES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 MARKET BY MEDICINE TYPE
12.1.2 MARKET BY PLATFORM
12.1.3 MARKET BY AGE GROUP
12.1.4 MARKET BY PRODUCT TYPE
12.1.5 MARKET BY REGION
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 MEDICINE TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 OTC
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 RX
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 PLATFORM
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 MOBILE
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 DESKTOP
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 AGE GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 BELOW 50
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 ABOVE 50
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 PRODUCT TYPE
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 MEDICATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HEALTH, WELLNESS & NUTRITION
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 PERSONAL CARE & ESSENTIALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY
17 REGION
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 REGIONAL OVERVIEW
18 EU-4 & UK
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 MEDICINE TYPE
18.3.1 MARKET SIZE & FORECAST
18.4 PLATFORM
18.4.1 MARKET SIZE & FORECAST
18.5 AGE GROUP
18.5.1 MARKET SIZE & FORECAST
18.6 PRODUCT TYPE
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 UK: MARKET SIZE & FORECAST
18.7.3 FRANCE: MARKET SIZE & FORECAST
18.7.4 ITALY: MARKET SIZE & FORECAST
18.7.5 SPAIN: MARKET SIZE & FORECAST
19 CENTRAL & EASTERN EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 MEDICINE TYPE
19.3.1 MARKET SIZE & FORECAST
19.4 PLATFORM
19.4.1 MARKET SIZE & FORECAST
19.5 AGE GROUP
19.5.1 MARKET SIZE & FORECAST
19.6 PRODUCT TYPE
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 POLAND: MARKET SIZE & FORECAST
19.7.2 NETHERLANDS: MARKET SIZE & FORECAST
19.7.3 RUSSIA: MARKET SIZE & FORECAST
19.7.4 SWITZERLAND: MARKET SIZE & FORECAST
19.7.5 CZECH REPUBLIC: MARKET SIZE & FORECAST
20 NORDIC COUNTRIES
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 MEDICINE TYPE
20.3.1 MARKET SIZE & FORECAST
20.4 PLATFORM
20.4.1 MARKET SIZE & FORECAST
20.5 AGE GROUP
20.5.1 MARKET SIZE & FORECAST
20.6 PRODUCT TYPE
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 DENMARK: MARKET SIZE & FORECAST
20.7.2 SWEDEN: MARKET SIZE & FORECAST
20.7.3 NORWAY: MARKET SIZE & FORECAST
20.7.4 FINLAND: MARKET SIZE & FORECAST
20.7.5 ICELAND: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
22 KEY COMPANY PROFILES
22.1 DOCMORRIS AG (ZUR ROSE GROUP)
22.1.1 BUSINESS OVERVIEW
22.1.2 KEY STRATEGIES
22.1.3 KEY STRENGTHS
22.1.4 KEY OPPORTUNITIES
22.2 SHOP APOTHEKE
22.2.1 BUSINESS OVERVIEW
22.2.2 KEY STRATEGIES
22.2.3 KEY STRENGTHS
22.2.4 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 AMX HOLDINGS
23.1.1 BUSINESS OVERVIEW
23.1.2 KEY STRATEGIES
23.1.3 KEY STRENGTHS
23.2 APTEKA.RU
23.2.1 BUSINESS OVERVIEW
23.2.2 KEY STRATEGIES
23.2.3 KEY STRENGTHS
23.3 APOTEA
23.3.1 BUSINESS OVERVIEW
23.3.2 KEY STRATEGIES
23.3.3 KEY STRENGTHS
23.4 APOTEKET
23.4.1 BUSINESS OVERVIEW
23.4.2 KEY STRATEGIES
23.4.3 KEY STRENGTHS
23.5 AZETA
23.5.1 BUSINESS OVERVIEW
23.5.2 KEY STRATEGIES
23.5.3 KEY STRENGTHS
23.6 BESTPHARMACY
23.6.1 BUSINESS OVERVIEW
23.6.2 KEY STRATEGIES
23.6.3 KEY STRENGTHS
23.7 CHEMIST4U
23.7.1 BUSINESS OVERVIEW
23.7.2 KEY STRATEGIES
23.7.3 KEY STRENGTHS
23.8 CHEMIST DIRECT
23.8.1 BUSINESS OVERVIEW
23.8.2 KEY STRATEGIES
23.8.3 KEY STRENGTHS
23.9 COCOONCENTER
23.9.1 BUSINESS OVERVIEW
23.9.2 KEY STRATEGIES
23.9.3 KEY STRENGTHS
23.10 DEONLINEDROGIST
23.10.1 BUSINESS OVERVIEW
23.10.2 KEY STRATEGIES
23.10.3 KEY STRENGTHS
23.11 EPHARMACY (EAPTEKA)
23.11.1 BUSINESS OVERVIEW
23.11.2 KEY STRATEGIES
23.11.3 KEY STRENGTHS
23.12 EURO-PHARAMAS
23.12.1 BUSINESS OVERVIEW
23.12.2 KEY STRATEGIES
23.12.3 KEY STRENGTHS
23.13 EXPRESS PHARMACY
23.13.1 BUSINESS OVERVIEW
23.13.2 KEY STRATEGIES
23.13.3 KEY STRENGTHS
23.14 EVERER GMBH
23.14.1 BUSINESS OVERVIEW
23.14.2 KEY STRATEGIES
23.14.3 KEY STRENGTHS
23.15 FRAMACIA INTERNACIONAL
23.15.1 BUSINESS OVERVIEW
23.15.2 KEY STRATEGIES
23.15.3 KEY STRENGTHS
23.16 HELSINKI UNIVERSITY PHARMACY [YLIOPISTAN APTEEKKI] (YA)
23.16.1 BUSINESS OVERVIEW
23.16.2 KEY STRATEGIES
23.16.3 KEY STRENGTHS
23.17 INDEX MEDICAL
23.17.1 BUSINESS OVERVIEW
23.17.2 KEY STRATEGIES
23.17.3 KEY STRENGTHS
23.18 INHOUSE PHARMACY
23.18.1 BUSINESS OVERVIEW
23.18.2 KEY STRATEGIES
23.18.3 KEY STRENGTHS
23.19 JUVALIS
23.19.1 BUSINESS OVERVIEW
23.19.2 KEY STRATEGIES
23.19.3 KEY STRENGTHS
23.20 LÉKÁRNA WPK
23.20.1 BUSINESS OVERVIEW
23.20.2 KEY STRATEGIES
23.20.3 KEY STRENGTHS
23.21 LLOYDS PHARMACY
23.21.1 BUSINESS OVERVIEW
23.21.2 KEY STRATEGIES
23.21.3 KEY STRENGTHS
23.22 LEKARNAR
23.22.1 BUSINESS OVERVIEW
23.22.2 KEY STRATEGIES
23.22.3 KEY STRENGTHS
23.23 LYF OG HEILSA
23.23.1 BUSINESS OVERVIEW
23.23.2 KEY STRATEGIES
23.23.3 KEY STRENGTHS
23.24 LYFJAVER
23.24.1 BUSINESS OVERVIEW
23.24.2 KEY STRATEGIES
23.24.3 KEY STRENGTHS
23.25 MEDEXPRESS ENTERPRISES
23.25.1 BUSINESS OVERVIEW
23.25.2 KEY STRATEGIES
23.25.3 KEY STRENGTHS
23.26 MONCOINSANTÉ
23.26.1 BUSINESS OVERVIEW
23.26.2 KEY STRATEGIES
23.26.3 KEY STRENGTHS
23.27 MISTLETOE PHARMACY
23.27.1 BUSINESS OVERVIEW
23.27.2 KEY STRATEGIES
23.27.3 KEY STRENGTHS
23.28 MYCARE
23.28.1 BUSINESS OVERVIEW
23.28.2 KEY STRATEGIES
23.28.3 KEY STRENGTHS
23.29 MEDISERVICE AG
23.29.1 BUSINESS OVERVIEW
23.29.2 KEY STRATEGIES
23.29.3 KEY STRENGTHS
23.30 MEDSERVICE LTD
23.30.1 BUSINESS OVERVIEW
23.30.2 KEY STRATEGIES
23.30.3 KEY STRENGTHS
23.31 MEDS
23.31.1 BUSINESS OVERVIEW
23.31.2 KEY STRATEGIES
23.31.3 KEY STRENGTHS
23.32 NEWPHARMA
23.32.1 BUSINESS OVERVIEW
23.32.2 KEY STRATEGIES
23.32.3 KEY STRENGTHS
23.33 OXFORD ONLINE PHARMACY
23.33.1 BUSINESS OVERVIEW
23.33.2 KEY STRATEGIES
23.33.3 KEY STRENGTHS
23.34 PRVALEKARNA
23.34.1 BUSINESS OVERVIEW
23.34.2 KEY STRATEGIES
23.34.3 KEY STRENGTHS
23.35 PARAFARMACIA-ONLINE
23.35.1 BUSINESS OVERVIEW
23.35.2 KEY STRATEGIES
23.35.3 KEY STRENGTHS
23.36 PHARMACY2U
23.36.1 BUSINESS OVERVIEW
23.36.2 KEY STRATEGIES
23.36.3 KEY STRENGTHS
23.37 PHARMACY DIRECT GB
23.37.1 BUSINESS OVERVIEW
23.37.2 KEY STRATEGIES
23.37.3 KEY STRENGTHS
23.38 PHARMA24
23.38.1 BUSINESS OVERVIEW
23.38.2 KEY STRATEGIES
23.38.3 KEY STRENGTHS
23.39 PROTEK GROUP
23.39.1 BUSINESS OVERVIEW
23.39.2 KEY STRATEGIES
23.39.3 KEY STRENGTHS
23.40 SBER EAPTEKA
23.40.1 BUSINESS OVERVIEW
23.40.2 KEY STRATEGIES
23.40.3 KEY STRENGTHS
23.41 SIMPLE ONLINE PHARMACY
23.41.1 BUSINESS OVERVIEW
23.41.2 KEY STRATEGIES
23.41.3 KEY STRENGTHS
23.42 THE INDEPENDENT PHARMACY
23.42.1 BUSINESS OVERVIEW
23.42.2 KEY STRATEGIES
23.42.3 KEY STRENGTHS
23.43 THE FRENCH PHARMACY
23.43.1 BUSINESS OVERVIEW
23.43.2 KEY STRATEGIES
23.43.3 KEY STRENGTHS
23.44 UK MEDS DIRECT
23.44.1 BUSINESS OVERVIEW
23.44.2 KEY STRATEGIES
23.44.3 KEY STRENGTHS
23.45 WEBMED PHARMACY
23.45.1 BUSINESS OVERVIEW
23.45.2 KEY STRATEGIES
23.45.3 KEY STRENGTHS
23.46 PHARMACY4U
23.46.1 BUSINESS OVERVIEW
23.46.2 KEY STRATEGIES
23.46.3 KEY STRENGTHS
23.47 VAMIDA
23.47.1 BUSINESS OVERVIEW
23.47.2 KEY STRATEGIES
23.47.3 KEY STRENGTHS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY REGION
25.2 MARKET BY MEDICINE TYPE
25.3 MARKET BY PLATFORM
25.4 MARKET BY AGE GROUP
25.5 MARKET BY PRODUCT TYPE
25.6 EU-4 & UK: MARKET SEGMENTATION
25.6.1 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE
25.6.2 EU-4 & UK E-PHARMACY MARKET BY PLATFORM
25.6.3 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP
25.6.4 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE
25.7 CENTRAL & EASTERN EUROPE: MARKET SEGMENTATION
25.7.1 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE
25.7.2 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM
25.7.3 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP
25.7.4 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE
25.8 NORDIC COUNTRIES: MARKET SEGMENTATION
25.8.1 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE
25.8.2 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM
25.8.3 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP
25.8.4 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE
26 APPENDIX
26.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF EUROPE E-PHARMACY MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 EUROPE E-PHARMACY MARKET DYNAMICS (2022)
EXHIBIT 4 IMPACT OF INCREASED E-HEALTH & E-PRESCRIPTION SERVICES
EXHIBIT 5 IMPACT OF INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS
EXHIBIT 6 AI IN E-PHARMACY
EXHIBIT 7 IMPACT OF STRATEGIC ACQUISITIONS FOR MARKET EXPANSION
EXHIBIT 8 IMPACT OF INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS
EXHIBIT 9 SERVICES OFFERED BY PHARMACY DELIVERY SOFTWARE SOLUTIONS
EXHIBIT 10 IMPACT OF INTERNET PENETRATION AMONG PATIENT POPULATION
EXHIBIT 11 INTERNET USE IN EUROPE
EXHIBIT 12 EUROPEAN COUNTRIES WITH INTERNET USE & ONLINE PURCHASE ATTITUDE (2023)
EXHIBIT 13 IMPACT OF INCREASED HOME HEALTHCARE DELIVERIES
EXHIBIT 14 ADVANTAGES OF E-PHARMACIES IN HOMECARE SETTINGS
EXHIBIT 15 IMPACT OF INCREASED HEALTH AWARENESS & SELF-MEDICATION
EXHIBIT 16 IMPACT OF INCREASED PATIENT POPULATION
EXHIBIT 17 PEOPLE AGED 65 & ABOVE WITH CHRONIC DISEASE PREVALENCE BY COUNTRY (%): 2018
EXHIBIT 18 IMPACT OF STRINGENT REGULATORY NORMS
EXHIBIT 19 IMPACT OF DATA BREACH & PRIVACY ISSUES
EXHIBIT 20 IMPACT OF COMPETITION FROM TRADITIONAL PHARMACIES
EXHIBIT 21 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: MARKET SHARE 2022 & 2028
EXHIBIT 22 EUROPE E-PHARMACY MARKET BY PLATFORM: MARKET SHARE 2022 & 2028
EXHIBIT 23 EUROPE E-PHARMACY MARKET BY AGE GROUP: MARKET SHARE 2022 & 2028
EXHIBIT 24 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: MARKET SHARE 2022 & 2028
EXHIBIT 25 EUROPE E-PHARMACY MARKET BY REGION: MARKET SHARE 2022 & 2028
EXHIBIT 26 EUROPE E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 27 FIVE FORCES ANALYSIS 2022
EXHIBIT 28 INCREMENTAL GROWTH BY MEDICINE TYPE 2022 & 2028
EXHIBIT 29 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028
EXHIBIT 30 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: SEGMENTAL OVERVIEW
EXHIBIT 31 COUNTRIES THAT ALLOW PRESCRIPTION & NON-PRESCRIPTION/OTC PRODUCT SALES THROUGH E-PHARMACIES
EXHIBIT 32 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: INCREMENTAL GROWTH
EXHIBIT 33 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: ABSOLUTE GROWTH
EXHIBIT 34 EUROPE OTC E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 35 EUROPE OTC E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 36 EUROPE RX E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 37 EUROPE RX E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY PLATFORM 2022 & 2028
EXHIBIT 39 EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028
EXHIBIT 40 EUROPE E-PHARMACY MARKET BY PLATFORM: SEGMENTAL OVERVIEW
EXHIBIT 41 EUROPE E-PHARMACY MARKET BY PLATFORM: INCREMENTAL GROWTH
EXHIBIT 42 EUROPE MOBILE E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 43 EUROPE MOBILE E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 44 PERSONAL COMPUTER PENETRATION PER CAPITA IN WESTERN EUROPE (2014–2019)
EXHIBIT 45 DESKTOP PENETRATION IN THE UK (2015–2020)
EXHIBIT 46 EUROPE DESKTOP E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 EUROPE DESKTOP E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY AGE GROUP 2022 & 2028
EXHIBIT 49 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028
EXHIBIT 50 THE EUROPE E-PHARMACY MARKET BY AGE GROUP SEGMENT: SEGMENTAL OVERVIEW
EXHIBIT 51 EUROPE E-PHARMACY MARKET BY AGE GROUP: INCREMENTAL GROWTH
EXHIBIT 52 EUROPE E-PHARMACY MARKET BY AGE GROUP: ABSOLUTE GROWTH
EXHIBIT 53 EUROPE BELOW 50 E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 54 INTERNET USERS IN EUROPE BY AGE GROUP WHO BOUGHT/ORDERED GOODS & SERVICES ONLINE (2010–2022) (%)
EXHIBIT 55 POLAND E-PHARMACY VISITS BY AGE GROUP (2016)
EXHIBIT 56 EUROPE BELOW 50 E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 57 INTERNET USERS IN EUROPE BY AGE GROUP WHO ORDERED GOODS & SERVICES THROUGH E-COMMERCE WEBSITES: 2010 TO 2022 (%)
EXHIBIT 58 POLAND ONLINE PHARMACY VISITS BY AGE GROUP 2016
EXHIBIT 59 EUROPE ABOVE 50 E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 EUROPE ABOVE 50 E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY PRODUCT TYPE 2022 & 2028
EXHIBIT 62 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028
EXHIBIT 63 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: SEGMENTAL OVERVIEW
EXHIBIT 64 EUROPE E-COMMERCE PURCHASE BY PRODUCT CATEGORY: 2021 (%)
EXHIBIT 65 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH
EXHIBIT 66 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH
EXHIBIT 67 PURCHASED MEDICATION PREFERENCE THROUGH E-PHARMACIES
EXHIBIT 68 EUROPE MEDICATION E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 EUROPE MEDICATION E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 70 TOP 10 NUTRITIONAL SUPPLEMENTS CONSUMED BY EUROPEANS (2022)
EXHIBIT 71 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 72 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 73 EUROPE PERSONAL CARE & COSMETIC PRODUCT EXPENDITURE: 2021 (BILLION)
EXHIBIT 74 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 76 EUROPE OTHERS E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 77 EUROPE OTHERS E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY REGION 2022 & 2028
EXHIBIT 79 EUROPE E-PHARMACY MARKET BY REGION 2022–2028
EXHIBIT 80 INTERNET USERS & E-SHOPPERS IN EU-4 & UK (2021)
EXHIBIT 81 COUNTRIES THAT ALLOW PRESCRIPTION & NON-PRESCRIPTION/OTC PRODUCT SALES THROUGH ONLINE PHARMACIES
EXHIBIT 82 EU-4 & UK E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 83 EU-4 & UK E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 84 INCREMENTAL GROWTH IN EU-4 & UK 2022 & 2028
EXHIBIT 85 SEARCH FOR E-PHARMACIES IN GERMANY: JANUARY 2020 TO JANUARY 2021 (%)
EXHIBIT 86 GERMANY E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 87 UK E-PRESCRIPTION STATISTICS (2019)
EXHIBIT 88 UK E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 89 NON-PRESCRIPTION MEDICINE SALES THROUGH E-PHARMACIES: ONLINE DRUGS SALES REGULATION
EXHIBIT 90 WILLINGNESS TO PURCHASE MEDICINES ONLINE: FRANCE
EXHIBIT 91 FRANCE E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 92 OPINION ABOUT ONLINE SALE OF MEDICINES IN ITALY (2019)
EXHIBIT 93 ITALY E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 94 SPAIN E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 95 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 96 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 97 INCREMENTAL GROWTH IN CENTRAL & EASTERN EUROPE 2022 & 2028
EXHIBIT 98 POLAND E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 99 NETHERLANDS FACTS (2020)
EXHIBIT 100 NETHERLANDS E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 101 RUSSIA E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 102 SWITZERLAND E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 103 INTERNET PENETRATION: CZECH REPUBLIC (2021)
EXHIBIT 104 CZECH REPUBLIC E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 105 NORDIC COUNTRIES E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 106 NORDIC COUNTRIES E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 107 INCREMENTAL GROWTH IN NORDIC COUNTRIES 2022 & 2028
EXHIBIT 108 DENMARK: ALLOCATION OF DIFFERENT ENTITIES OF PHARMACIES (2020)
EXHIBIT 109 DENMARK E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 110 SWEDEN PHARMACY & E-PHARMACY STATISTICS (2022)
EXHIBIT 111 SWEDEN E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 112 NORWAY E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 113 FINLAND E-PHARMACY MARKET 2022–2028 ($ BILLION)
EXHIBIT 114 ICELAND E-PHARMACY MARKET 2022–2028 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2016–2022
TABLE 3 E-PRESCRIPTION GENERATION IN EUROPEAN COUNTRIES
TABLE 4 EUROPE E-PHARMACY MARKET: STRATEGIC PARTNERSHIPS, M&A & COLLABORATIONS
TABLE 5 SELF-MEDICATION PREVALENCE BY THERAPY AREAS IN EUROPEAN COUNTRIES (2020)
TABLE 6 DATA BREACHING & CYBERATTACK ISSUES
TABLE 7 EUROPE E-PHARMACY MARKET: SEGMENTAL DATA COMPARISON (2022–2028)
TABLE 8 EUROPE OTC E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 9 EUROPE OTC E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 10 EUROPE RX E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 11 EUROPE RX E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 12 EUROPE SMARTPHONE PENETRATION & USERS (2021)
TABLE 13 EUROPE MOBILE E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 14 EUROPE MOBILE E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 15 EUROPE DESKTOP E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 16 EUROPE DESKTOP E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 17 RESPONDENTS WHO PURCHASED MEDICINE THROUGH ONLINE PHARMACIES IN EUROPE (2021)
TABLE 18 EUROPE BELOW 50 E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 19 EUROPE BELOW 50 E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 20 RESPONDENTS WHO PURCHASED MEDICINE FROM ONLINE PHARMACIES IN EUROPE (2021)
TABLE 21 EUROPE ABOVE 50 E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 22 EUROPE ABOVE 50 E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 23 EUROPE MEDICATION E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 24 EUROPE MEDICATION E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 25 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 26 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 27 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 28 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 29 EUROPE OTHERS E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 30 EUROPE OTHERS E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 31 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 32 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 33 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 34 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 35 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 36 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 37 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 38 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
TABLE 39 SOME LEADING E-PHARMACIES IN GERMANY (2023)
TABLE 40 SOME LEADING ONLINE PHARMACIES IN ITALY
TABLE 41 SOME LEADING E-PHARMACIES IN SPAIN (2022)
TABLE 42 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 43 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 44 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 45 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 46 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 47 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 48 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 49 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
TABLE 50 CONSUMER OPINIONS ON ONLINE SALES OF MEDICINE BY AGE GROUP IN RUSSIA: 2020–2021 (%)
TABLE 51 TOP FIVE PRESCRIPTION DELIVERY APPS & WEBSITES: SWITZERLAND
TABLE 52 COMPARISON OF E-PHARMACY MARKET IN NORDIC COUNTRIES
TABLE 53 INTERNET PENETRATION IN NORDIC COUNTRIES
TABLE 54 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 55 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 56 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 57 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 58 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 59 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 60 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 61 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
TABLE 62 NORWAY: OVERVIEW OF ONLINE SALE OF MEDICINES
TABLE 63 CURRENT MARKET LANDSCAPE OF E-PHARMACY IN NORWAY
TABLE 64 TRADITIONAL PHARMACY & E-PHARMACY SERVICES MARKET SHARE IN ICELAND
TABLE 65 EUROPE E-PHARMACY MARKET BY REGION 2022–2028 ($ BILLION)
TABLE 66 EUROPE E-PHARMACY MARKET BY REGION 2022–2028 (%)
TABLE 67 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 68 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 69 EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 70 EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 71 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 72 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 73 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 74 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
TABLE 75 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 76 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 77 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 78 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 79 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 80 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 81 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 82 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
TABLE 83 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 84 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 85 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 86 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 87 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 88 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 89 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 90 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
TABLE 91 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 ($ BILLION)
TABLE 92 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022–2028 (%)
TABLE 93 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 ($ BILLION)
TABLE 94 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022–2028 (%)
TABLE 95 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 ($ BILLION)
TABLE 96 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022–2028 (%)
TABLE 97 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 ($ BILLION)
TABLE 98 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
